Published in J Neural Transm (Vienna) on September 14, 2006
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Reperfusion promotes mitochondrial biogenesis following focal cerebral ischemia in rats. PLoS One (2014) 0.83
Functional proteomics of adenosine triphosphatase system in the rat striatum during aging. Neural Regen Res (2012) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol (2000) 2.71
Spectrophotometric assay of cytochrome c oxidase. Methods Biochem Anal (1955) 2.47
Synaptic and non-synaptic mitochondria from rat brain: isolation and characterization. J Neurochem (1977) 1.40
Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life (2000) 1.20
The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann N Y Acad Sci (2000) 1.16
Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic Biol Med (1995) 1.05
The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm (Vienna) (2002) 1.01
Mitochondrial respiration in the low oxygen environment of the cell. Effect of ADP on oxygen kinetics. Biochim Biophys Acta (1998) 0.93
Oxidation and reduction of soluble cytochrome c by membrane-bound oxidase and reductase systems. J Biol Chem (1974) 0.92
Barbiturate protection in acute focal cerebral ischemia. Stroke (1974) 0.92
Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat. Mech Ageing Dev (1995) 0.89
Age-related increase in oxidized proteins in mouse synaptic mitochondria. Brain Res (1996) 0.89
Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett (1997) 0.86
Ischemia and aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol Aging (1986) 0.86
Energy metabolism in disorders of the nervous system. Rev Neurol (Paris) (1988) 0.83
Energy metabolism of synaptosomal subpopulations from different neuronal systems of rat hippocampus: effect of L-acetylcarnitine administration in vivo. Neurochem Res (1999) 0.82
Structural and functional aspects of the respiratory chain of synaptic and nonsynaptic mitochondria derived from selected brain regions. J Bioenerg Biomembr (1991) 0.82
The effect of anesthetics upon labile phosphates and upon extra- and intracellular lactate, pyruvate and bicarbonate concentrations in the rat brain. Acta Physiol Scand (1970) 0.82
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development. Mech Ageing Dev (1989) 0.81
The effect of halothane anaesthesia upon cerebral oxygen consumption in the rat. Acta Anaesthesiol Scand (1976) 0.80
Influence of anaesthetics on the balance between production and utilization of energy in the brain. J Neurochem (1974) 0.79
Coenzymes Q9 and Q10, vitamin E and peroxidation in rat synaptic and non-synaptic occipital cerebral cortex mitochondria during ageing. Biol Chem (2001) 0.79
Influence of anesthetics on metabolic, functional and pathological responses to regional cerebral ischemia. Stroke (1975) 0.78
Cerebral cortex synaptic heavy mitochondria may represent the oldest synaptic mitochondrial population: biochemical heterogeneity and effects of L-acetylcarnitine. J Bioenerg Biomembr (2000) 0.77
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging. Neurochem Res (1991) 0.77
A critique on the preparation and enzymatic characterization of synaptic and nonsynaptic mitochondria from hippocampus. Cell Mol Neurobiol (1989) 0.77
Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine. Neurochem Res (1994) 0.77
Pharmacology of lazaroids and brain energy metabolism: a review. Pharmacol Rev (1997) 0.77
Modifications of synaptosomal plasma membrane protein composition in various brain regions during aging. Int J Dev Neurosci (1992) 0.76
The effect of age on glucose and energy metabolism in brain cortex of rats. Arch Gerontol Geriatr (1985) 0.76
Changes of mitochondrial membrane proteins in rat cerebellum during aging. Neurochem Res (1988) 0.76
Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect. Neurochem Res (1992) 0.76
Effect of CDP-choline treatment on mitochondrial and synaptosomal protein composition in different brain regions during aging. Int J Dev Neurosci (1993) 0.76
ATPases of synaptic plasma membranes from hippocampus after ischemia and recovery during ageing. Neurochem Res (2002) 0.76
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex. Neurochem Res (1998) 0.75
Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. Drugs Aging (1995) 0.75
Ageing is associated with changes in glutamate release, protein tyrosine kinase and Ca2+/calmodulin-dependent protein kinase II in rat hippocampus. Eur J Pharmacol (1996) 0.75
Changes induced by ischemia on some cerebral enzymatic activities related to energy transduction and amino acid metabolism. Neurochem Res (1983) 0.75
Structural damage induced by peroxidation may account for functional impairment of heavy synaptic mitochondria. Free Radic Res (2002) 0.75
Influence of nitrous oxide on local cerebral blood flow in awake, minimally restrained rats. J Cereb Blood Flow Metab (1981) 0.75
Relationship between cerebral energy metabolism in parietotemporal cortex and hippocampus and mental activity during aging in rats. J Neural Transm (Vienna) (2004) 0.75
Effect of hypoxia on mitochondrial protein composition of cerebral cortex during aging. Neurochem Res (1991) 0.75
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus. Eur J Basic Appl Histochem (1991) 0.75
Effect of nitrous oxide on local cerebral glucose utilization in rats. J Cereb Blood Flow Metab (1982) 0.75
Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. Diabetologia (2001) 2.25
Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm (Vienna) (1998) 1.90
Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci (1998) 1.56
A translation of Otto Binswanger's article, 'The delineation of the generalized progressive paralyses'. 1894. Arch Neurol (1991) 1.44
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Influence of systemic and cerebral vascular factors on the cerebrospinal fluid pulse waves. J Neurosurg (1977) 1.11
Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl (2007) 1.10
Effect of pyritinol-GCl on blood flow and oxidative metabolism of the brain in patients with dementia. Arzneimittelforschung (1977) 1.06
Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients. Neurobiol Dis (2009) 1.05
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann N Y Acad Sci (1999) 1.03
Natural distribution and occurrence of coenzyme Q homologues. Membr Biochem (1992) 1.02
Odour and taste sensitivity is associated with body weight and extent of misreporting of body weight. Eur J Clin Nutr (2006) 1.01
Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci (1994) 0.95
Brain-derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp Neurol (1999) 0.95
Affective disorders, antidepressant drugs and brain metabolism. Mol Psychiatry (2003) 0.92
Mitochondrial activities of rat heart during ageing. Mech Ageing Dev (1994) 0.91
Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol (1993) 0.91
Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett (1991) 0.90
Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res (1990) 0.90
Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci (1993) 0.89
Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat. Mech Ageing Dev (1995) 0.89
Drug and alcohol use among patients admitted to a Danish trauma centre: a prospective study from a regional trauma centre in Scandinavia. Eur J Emerg Med (2004) 0.88
Ischemia and aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol Aging (1986) 0.86
Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr (2004) 0.86
Disturbed oxidative metabolism in organic brain syndrome caused by bismuth in skin creams. Lancet (1976) 0.86
Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett (1997) 0.86
Pharmacotherapy and prevention of vascular dementia. CNS Neurol Disord Drug Targets (2011) 0.85
Streptozotocin increases free fatty acids and decreases phospholipids in rat brain. J Neural Transm (Vienna) (1998) 0.84
Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett (1994) 0.84
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm Suppl (1995) 0.83
Senile dementia and Alzheimer's disease. Brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.83
Structural and functional aspects of the respiratory chain of synaptic and nonsynaptic mitochondria derived from selected brain regions. J Bioenerg Biomembr (1991) 0.82
Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J Neural Transm (Vienna) (2003) 0.82
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development. Mech Ageing Dev (1989) 0.81
Interrelation between cerebral energy metabolism and behaviour in a rat model of permanent brain vessel occlusion. Brain Res (1999) 0.81
The effect of carbon dioxide on cerebral blood flow and cerebral metabolism in dogs. Br J Anaesth (1975) 0.81
Malaria dipsticks beneficial for IMCI in Cambodia. Trop Med Int Health (2003) 0.81
Synaptic and non-synaptic mitochondria from rat cerebral cortex. Characterization and effect of pharmacological treatment on some enzyme activities related to energy transduction. Farmaco Sci (1983) 0.80
Decline and preservation of reversal learning abilities and acquisition in the course of senescence. Neurosci Lett (1995) 0.80
From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain. J Neural Transm (Vienna) (2006) 0.80
Coenzymes Q9 and Q10, vitamin E and peroxidation in rat synaptic and non-synaptic occipital cerebral cortex mitochondria during ageing. Biol Chem (2001) 0.79
The effect of stepwise arterial hypotension on blood flow and oxidative metabolism of the brain. Pflugers Arch (1974) 0.79
Alois Alzheimer revisited: differences in origin of the disease carrying his name. J Neural Transm (Vienna) (2006) 0.79
Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. Neurochem Res (1995) 0.79
Holeboard maze-learning deficits and brain monoaminergic neurotransmitter concentrations in rats after intracerebroventricular injection of 3-bromopyruvate. Pharmacol Biochem Behav (1995) 0.79
Psychometry in aging and dementia. Arch Gerontol Geriatr (1985) 0.78
Cerebral endogenous substrate utilization during the recovery period after profound hypoglycemia. J Neurosci Res (1984) 0.78
Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study. Neurotox Res (2008) 0.78
Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. J Neural Transm Suppl (2007) 0.78
Superoxide dismutase and cytochrome oxidase activities in light and heavy synaptic mitochondria from rat cerebral cortex during aging. J Neurosci Res (1989) 0.78
Effect of adrenalectomy and corticosterone substitution on glucose and glycogen metabolism in rat brain. J Neural Transm (Vienna) (1996) 0.78
[Cerebral blood flow and brain metabolism findings in neuropsychiatric patients]. Nervenarzt (1966) 0.78
Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate. J Neural Transm Park Dis Dement Sect (1990) 0.78
[Blood flow and oxidative metabolism of the brain in patients with dementia (author's transl)]. J Neurol (1975) 0.78
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing. Neuroscience (2012) 0.77
The abnormally aged brain. Its blood flow and oxidative metabolism. A review - part II. Arch Gerontol Geriatr (1982) 0.77
Acetylcholine esterase sensitivity to chronic administration of diphenylhydantoin and effects on cerebral enzymatic activities related to energy metabolism. Neurochem Res (1980) 0.77
Blood flow and oxidative metabolism of the brain in patients with schizophrenia. Psychiatr Clin (Basel) (1975) 0.77
Normal and abnormal circulation and oxidative metabolism in the aging human brain. J Cereb Blood Flow Metab (1982) 0.77
Coenzyme Q, Vitamin E and Apo-E alleles in Alzheimer Disease. Biofactors (2003) 0.77
Cerebral cortex synaptic heavy mitochondria may represent the oldest synaptic mitochondrial population: biochemical heterogeneity and effects of L-acetylcarnitine. J Bioenerg Biomembr (2000) 0.77
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging. Neurochem Res (1991) 0.77
Pharmacology of lazaroids and brain energy metabolism: a review. Pharmacol Rev (1997) 0.77
Age-related changes by hypoxia and TRH analogue on synaptic ATPase activities. Neurobiol Aging (1994) 0.77
Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine. Neurochem Res (1994) 0.77
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus. Arch Int Pharmacodyn Ther (1986) 0.77
A critique on the preparation and enzymatic characterization of synaptic and nonsynaptic mitochondria from hippocampus. Cell Mol Neurobiol (1989) 0.77
Increased ATP production during long-term brain ischemia in rats in the presence of propentofylline. Eur J Pharmacol (1998) 0.77
Comparative studies of the electroencephalogram and the cerebral oxidative metabolism in patients with liver cirrhosis. Klin Wochenschr (1975) 0.77
Brain activity during intra- and cross-modal priming: new empirical data and review of the literature. Neuropsychologia (2004) 0.77
Cerebral glucose and energy metabolism, cerebral oxygen consumption, and blood flow in arterial hypoxaemia. Acta Neurochir (Wien) (1978) 0.77
Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin. J Cereb Blood Flow Metab (1992) 0.77
Central administration of alloxan impairs glucose tolerance in rats. J Neural Transm (Vienna) (2005) 0.76
Effect of CDP-choline treatment on mitochondrial and synaptosomal protein composition in different brain regions during aging. Int J Dev Neurosci (1993) 0.76
Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J Neurosci Res (1992) 0.76
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia. Ann N Y Acad Sci (1999) 0.76
Increase in vulnerability of middle-aged rat brain to lead by cerebral energy depletion. Brain Res Bull (2000) 0.76
Mitochondrial factors involved in Parkinson's disease by MPTP toxicity in Macaca fascicularis and drug effect. Neurochem Res (1992) 0.76
Glutamate decarboxylase-immunoreactive neurons in the aging rat hippocampus are more resistant to ischemia than CA1 pyramidal cells. Neurosci Lett (1988) 0.76
ATPases of synaptic plasma membranes from hippocampus after ischemia and recovery during ageing. Neurochem Res (2002) 0.76
Long-term cultivation of a neuroblastoma cell line in medium with reduced serum content as a model system for neuronal aging? Arch Gerontol Geriatr (2008) 0.76
Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia. Farmaco Sci (1984) 0.76
Age-related histochemical staining patterns of glycosaminoglycans in cell nuclei of different regions of the rat brain: a pilot study. Arch Gerontol Geriatr (2004) 0.76
Modifications by hypoxia and drug treatment of cerebral ATPase plasticity. Neurochem Res (1994) 0.76
Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease? J Neural Transm (Vienna) (2000) 0.76
The effect of age on glucose and energy metabolism in brain cortex of rats. Arch Gerontol Geriatr (1985) 0.76
Effects of long-term recovery from transient cerebral ischemia in rat brain: tissue levels of acetylcholine, monoamines, and their metabolites. Neurochem Res (1993) 0.76
Age-related alterations of skeletal muscle metabolism by intermittent hypoxia and TRH-analogue treatment. Pharmacol Res (1995) 0.76
Modifications of synaptosomal plasma membrane protein composition in various brain regions during aging. Int J Dev Neurosci (1992) 0.76
Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brain. J Neural Transm (Vienna) (2001) 0.75
Age-related alterations by chronic intermittent hypoxia on cerebral synaptosomal ATPase activities. J Neural Transm Suppl (1994) 0.75
Somatostatin and Alzheimer's disease. J Neurol (1987) 0.75
Modification of the skeletal muscle energy metabolism induced by intermittent normobaric hypoxia and treatment with biological pyrimidines. Farmaco Sci (1985) 0.75
Causes and consequences of neuronal energy deficit in sporadic Alzheimer's disease. Ann N Y Acad Sci (1997) 0.75
[On the question of treatment possibility of cerebral hypoglycoxydoses]. Acta Neurochir (Wien) (1967) 0.75
Favorable response of chronic candidas to amphotericin B. Acta Paediatr Scand (1967) 0.75
[Cardiac magnetic resonance and uremic cardiomyopathy]. G Ital Nefrol (2014) 0.75
[Brain metabolism studies under the treatment with pyrithioxin]. Dtsch Z Nervenheilkd (1966) 0.75